Experimental evidence in other cancers has demonstrated that targeting laminin‐integrin interactions can reduce tumor cell invasiveness and metastasis, supporting the feasibility of translating LAMC2‐based therapeutic strategies into clinical practice.[45] In our study, we preliminarily validated the critical role of LAMC2 in promoting tumor invasiveness in PSCC through functional experiments. The gene discussed is LAMC2; the disease is neoplasm.